Navigation Links
Innophos to Host Investor Day
Date:11/3/2011

CRANBURY, N.J., Nov. 3, 2011 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), the leading North American producer of specialty phosphate products for the food, beverage, pharmaceutical, oral care and industrial end markets, today announced that Randy Gress, Chief Executive Officer, and other members of senior management will be hosting an investor day in New York City on November 9, 2011.  Management will be discussing the Company's position in the marketplace and growth drivers for the future.  

The meeting will take place at the Citigroup Center, 153 East 53rd Street, and is scheduled to begin at 8:30 a.m.  To access a live or replay webcast of the event, please go to www.innophos.com Investor Relations Upcoming Events. The replay will be available for one year and will begin two hours following the conclusion of the investor day.

About Innophos Holdings, Inc.Innophos is the leading North American producer of specialty phosphate products, offering performance-critical ingredients with applications in food, beverage, pharmaceutical, oral care and industrial end markets. Innophos produces complex phosphates to the highest standards of quality and consistency demanded by customers worldwide, develops new and innovative phosphate-based products to address specific customer applications and supports these high-value products with industry-leading technical service. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and San Jose de Iturbide (Mission Hills), Guanajuato (Mexico). For more information please see www.innophos.com. 'IPHS-G' IPHS-G'Contact Information:Innophos Holdings, Inc.

FTI Consulting, Inc.Investor Relations: (609) 366-1299

Alexandra Tramont/Matt Steinberginvestor.relations@innophos.com

212-850-5600
'/>"/>

SOURCE Innophos Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Innophos Holdings, Inc. Announces Acquisition of Kelatron Corporation
2. Innophos Holdings, Inc. Declares Quarterly Dividend
3. Innophos to Present at 2011 Oppenheimer Industrials Conference
4. Innophos Holdings, Inc. Declares Dividend of $0.25 Per Share; Increases Rate By 47%
5. Innophos Holdings, Inc. Announces Annual Meeting
6. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
7. ViroPharma to Participate in Two November Healthcare Investor Conferences
8. Vermillion Engages Liolios Group to Lead Investor Relations Program
9. Hologic to Host Investor Presentation at RSNA 2011
10. Express Scripts to Present at Investor Conferences in November
11. China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):